We are committed to advancing radioisotope technology
NorthStar Medical Radioisotopes, LLC is a privately held nuclear medicine technology company committed to providing reliable and environmentally friendly radioisotope supply solutions to meet patient needs and advance clinical research. Founded in 2006 and based in Beloit, Wisconsin, NorthStar is a wholly-owned subsidiary of NorthStar Medical Technologies, LLC.
Partial funding for the RadioGenix® System (technetium Tc 99m generator) and for the company’s Mo-99 production efforts has been provided by the U.S. Department of Energy’s (DOE) National Nuclear Security Administration (NNSA). NorthStar was the first company to be awarded a full $50 million Cooperative Agreement from the NNSA. To date, NorthStar has received three Cooperative Agreements. The first two Cooperative Agreements were each valued at $50 million which means that the Company invests $25 million and the NNSA matches the Company’s investment dollar for dollar. The third Cooperative Agreement was for $30 million, with the Company required to invest $15 million to receive $15 million in matching funds. In addition, as part of the NNSA’s program, the Company has received approximately $40 million in supporting work from DOE National Labs.
In addition to NNSA funding, NorthStar partners with private investors through preferred stock financing.
Our valued partners include: